The text addresses regulatory requirements for suppliers to disclose affiliations with providers or suppliers that have issues such as uncollected debt, payment suspensions, exclusions from Medicare, Medicaid, or CHIP, or revoked billing privileges. It outlines the Stark Law, which prohibits physicians with financial relationships with commercial laboratories from referring patients for testing unless specific exceptions apply. These exceptions include fair market value compensation, payments for commercial laboratory services, ancillary services provided in a physician's office, physician investments in publicly traded companies with significant equity, and certain rental arrangements. Amendments to the Anti-Kickback Statute and Stark Law aim to support coordinated care and value-based compensation. Laboratories are included under Stark Law exceptions but are excluded from Anti-Kickback Statute safe harbors. The company seeks compliance with all U.S. and state fraud and abuse laws but acknowledges uncertainty regarding future application and potential sanctions, including exclusion from healthcare programs and fines.
Prophase Labs Inc's Comment on Supply Chain
The text addresses regulatory requirements for suppliers to disclose affiliations with providers or suppliers that have issues such as uncollected debt, payment suspensions, exclusions from Medicare, Medicaid, or CHIP, or revoked billing privileges. It outlines the Stark Law, which prohibits physicians with financial relationships with commercial laboratories from referring patients for testing unless specific exceptions apply. These exceptions include fair market value compensation, payments for commercial laboratory services, ancillary services provided in a physician's office, physician investments in publicly traded companies with significant equity, and certain rental arrangements. Amendments to the Anti-Kickback Statute and Stark Law aim to support coordinated care and value-based compensation. Laboratories are included under Stark Law exceptions but are excluded from Anti-Kickback Statute safe harbors. The company seeks compliance with all U.S. and state fraud and abuse laws but acknowledges uncertainty regarding future application and potential sanctions, including exclusion from healthcare programs and fines.
Sources:
Prophase Labs Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Prophase Labs Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
